The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Lysosomes as mediators of drug resistance in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
The machinery of macroautophagy
Feng, Y., He, D., Yao, Z., & Klionsky, D. J. (2014) · Cell Research · doi:10.1038/cr.2013.168 · Cited by 2,083
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Settembre, C., Zoncu, R., Medina, D. L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M. C., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.32 · Cited by 1,920
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60196-2 · Cited by 1,446
Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB
Medina, D. L., Di Paola, S., Peluso, I., Armani, A., De Stefani, D., Venditti, R., Montefusco, S., Scotto-Rosato, A., Prezioso, C., Forrester, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3114 · Cited by 1,413
MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB
Martina, J. A., Chen, Y., Gucek, M., & Puertollano, R. (2012) · Autophagy · doi:10.4161/auto.19653 · Cited by 1,333
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
Palmieri, M., Impey, S., Kang, H., di Ronza, A., Pelz, C., Sardiello, M., & Ballabio, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr306 · Cited by 1,022
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
The lysosome: from waste bag to potential therapeutic target
Appelqvist, H., Wäster, P., Kågedal, K., & Öllinger, K. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt022 · Cited by 772
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Medina, D. L., Fraldi, A., Bouche, V., Annunziata, F., Mansueto, G., Spampanato, C., Puri, C., Pignata, A., Martina, J. A., Sardiello, M., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.016 · Cited by 716
Lysosomal cell death at a glance
Aits, S., & Jäättelä, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.091181 · Cited by 667
STRUCTURE, FUNCTION AND REGULATION OF THE VACUOLAR (H+)-ATPase
Stevens, T. H., & Forgac, M. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.779 · Cited by 588
Safaei, R., Larson, B. J., Cheng, T. C., Gibson, M. A., Otani, S., Naerdemann, W., & Howell, S. B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0102 · Cited by 564
P-glycoprotein and multidrug resistance
Gottesman, M. M., Pastan, I., & Ambudkar, S. V. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80091-8 · Cited by 560
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
Callaghan, R., Luk, F., & Bebawy, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056176 · Cited by 453
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Gonen, N., & Assaraf, Y. G. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.07.002 · Cited by 437
Self-citationDooley, J. S., & Ala, A. (2010) · Evidence‐Based Gastroenterology and Hepatology · doi:10.1002/9781444314403.ch31 · Cited by 386
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Regulated secretion of conventional lysosomes
Andrews, N. W. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01794-3 · Cited by 353
Cathepsin cysteine proteases in cardiovascular disease
Lutgens, S. P. M., Cleutjens, K. B. J. M., Daemen, M. J. A. P., & Heeneman, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7924com · Cited by 351
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Gotink, K. J., Broxterman, H. J., Labots, M., de Haas, R. R., Dekker, H., Honeywell, R. J., Rudek, M. A., Beerepoot, L. V., Musters, R. J., Jansen, G., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1667 · Cited by 345
Self-citationMolecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
Self-citationCopper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z., Terada, K., Furukawa, T., Yang, X., Gao, H., Miura, N., Sugiyama, T., et al. (2000) · PubMed · Cited by 328
Cancer-associated lysosomal changes: friends or foes?
Kallunki, T., Olsen, O. D., & Jäättelä, M. (2013) · Oncogene · doi:10.1038/onc.2012.292 · Cited by 298
Wilson Disease Protein ATP7B Utilizes Lysosomal Exocytosis to Maintain Copper Homeostasis
Polishchuk, E. V., Concilli, M., Iacobacci, S., Chesi, G., Pastore, N., Piccolo, P., Paladino, S., Baldantoni, D., van IJzendoorn, S. C. D., Chan, J., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.04.033 · Cited by 284
Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic Implications
Kaufmann, A. M., & Krise, J. P. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20792 · Cited by 284
Schindler, M., Grabski, S., Hoff, E., & Simon, S. M. (1996) · Biochemistry · doi:10.1021/bi952234e · Cited by 269
Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy
Altan, N., Chen, Y., Schindler, M., & Simon, S. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1583 · Cited by 265
Multidrug resistance: Physiological principles and nanomedical solutions
Kunjachan, S., Rychlik, B., Storm, G., Kiessling, F., & Lammers, T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.018 · Cited by 259
Song, I.-S., Savaraj, N., Siddik, Z. H., Liu, P., Wei, Y., Wu, C. J., & Kuo, M. T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1543.3.12 · Cited by 259
Kazmi, F., Hensley, T., Pope, C., Funk, R. S., Loewen, G. J., Buckley, D. B., & Parkinson, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050054 · Cited by 259
Holzer, A. K., Samimi, G., Katano, K., Naerdemann, W., Lin, X., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001198 · Cited by 245
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
Assaraf, Y. G. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.09.001 · Cited by 235
Self-citationThe Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
Zhitomirsky, B., & Assaraf, Y. G. (2015) · Oncotarget · doi:10.18632/oncotarget.2732 · Cited by 225
Self-citationP-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
Yamagishi, T., Sahni, S., Sharp, D. M., Arvind, A., Jansson, P. J., & Richardson, D. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.514091 · Cited by 220
van den Berghe, P. V. E., Folmer, D. E., Malingré, H. E. M., van Beurden, E., Klomp, A. E. M., van de Sluis, B., Merkx, M., Berger, R., & Klomp, L. W. J. (2007) · Biochemical Journal · doi:10.1042/bj20070705 · Cited by 217
Groth-Pedersen, L., Ostenfeld, M. S., Høyer-Hansen, M., Nylandsted, J., & Jäättelä, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3520 · Cited by 215
The potential role of lysosomes in tissue distribution of weak bases
Macintyre, A. C., & Cutler, D. J. (1988) · Biopharmaceutics & Drug Disposition · doi:10.1002/bod.2510090602 · Cited by 208
Rationally designed nanovehicles to overcome cancer chemoresistance
Livney, Y. D., & Assaraf, Y. G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.006 · Cited by 205
Self-citationLAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis
Liu, B., Du, H., Rutkowski, R., Gartner, A., & Wang, X. (2012) · Science · doi:10.1126/science.1220281 · Cited by 195
Combating apoptosis and multidrug resistant cancers by targeting lysosomes
Groth-Pedersen, L., & Jäättelä, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.05.021 · Cited by 193
Subcellular Localization and Activity of Multidrug Resistance Proteins
Rajagopal, A., & Simon, S. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-11-0704 · Cited by 190
Yanes, R. E., Tarn, D., Hwang, A. A., Ferris, D. P., Sherman, S. P., Thomas, C. R., Lu, J., Pyle, A. D., Zink, J. I., & Tamanoi, F. (2013) · Small · doi:10.1002/smll.201201811 · Cited by 163
Chapuy, B., Koch, R., Radunski, U., Corsham, S., Cheong, N., Inagaki, N., Ban, N., Wenzel, D., Reinhardt, D., Zapf, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.103 · Cited by 162
Blair, B. G., Larson, C., Safaei, R., & Howell, S. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0311 · Cited by 154
Öhrvik, H., Nose, Y., Wood, L. K., Kim, B.-E., Gleber, S.-C., Ralle, M., & Thiele, D. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311749110 · Cited by 140
Vesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes
Hurwitz, S. J., Terashima, M., Mizunuma, N., & Slapak, C. A. (1997) · Blood · doi:10.1182/blood.v89.10.3745 · Cited by 137
Kalayda, G. V., Wagner, C. H., Buß, I., Reedijk, J., & Jaehde, U. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-175 · Cited by 120
Mechanisms of Amine Accumulation in, and Egress from, Lysosomes
Goldman, S. D. B., Funk, R. S., Rajewski, R. A., & Krise, J. P. (2009) · Bioanalysis · doi:10.4155/bio.09.128 · Cited by 114
Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells
Bertinato, J., Swist, E., Plouffe, L. J., Brooks, S. P. J., & L’Abbé, M. R. (2008) · Biochemical Journal · doi:10.1042/bj20071025 · Cited by 108
Role of transporters in the distribution of platinum-based drugs
Harrach, S., & Ciarimboli, G. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00085 · Cited by 108
The role of P-glycoprotein in drug resistance in multiple myeloma
Abraham, J., Salama, N. N., & Azab, A. K. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.907890 · Cited by 106
Adar, Y., Stark, M., Bram, E. E., Nowak-Sliwinska, P. M., van den Bergh, H., Szewczyk, G. M., Sarna, T., Składanowski, A., Griffioen, A. W., & Assaraf, Y. G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.30 · Cited by 105
Self-citationGong, Y., Duvvuri, M., & Krise, J. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306606200 · Cited by 101
Ouar, Z., Bens, M., Vignes, C., Paulais, M., PRINGEL, C., Fleury‐Feith, J., Cluzeaud, F., Lacave, R., & Vandewalle, A. (2003) · Biochemical Journal · doi:10.1042/bj20021411 · Cited by 100
Duvvuri, M. (2005) · Frontiers in bioscience · doi:10.2741/1634 · Cited by 98
Chen, H. H. W., Yan, J., Chen, W.-C., Kuo, M. T., Lai, Y.-H., Lai, W. W., Liu, H., & Su, W. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.06.011 · Cited by 93
Säftig, P., & Sandhoff, K. (2013) · Nature · doi:10.1038/nature12692 · Cited by 92
Chapuy, B., Panse, M. V., Radunski, U. K., Koch, R., Wenzel, D., Inagaki, N., Haase, D. T., Trümper, L. H. P., & Wulf, G. G. (2009) · Haematologica · doi:10.3324/haematol.2009.008631 · Cited by 91
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
Chauhan, S. S., Liang, X., Su, A. W., Panandiker, A. S. P., Shen, D. W., Hanover, J. A., & Gottesman, M. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600861 · Cited by 90
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer
Kim, E. S., Tang, X., Peterson, D. R., Kilari, D., Chow, C.-W. B., Fujimoto, J., Kalhor, N., Swisher, S. G., Stewart, D. J., Wistuba, I. I., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.04.005 · Cited by 88
Lysosome: the cell's ‘suicidal bag’ as a promising cancer target
Gyparaki, M.-T., & Papavassiliou, A. G. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.009 · Cited by 80
Advances in the Molecular Detection of ABC Transporters Involved in Multidrug Resistance in Cancer
Gillet, J., & Gottesman, M. M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795163931 · Cited by 79
Molinari, A., Calcabrini, A., Meschini, S., Stringaro, A., Crateri, P., Toccacieli, L., Marra, M., Colone, M., Cianfriglia, M., & Arancia, G. (2002) · Current Protein and Peptide Science · doi:10.2174/1389203023380413 · Cited by 78
Blair, B. G., Larson, C., Adams, P. L., Abada, P., Pesce, C. E., Safaei, R., & Howell, S. B. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068411 · Cited by 72
Lysosomal storage disease: Gene therapy on both sides of the blood–brain barrier
Aronovich, E. L., & Hackett, P. B. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.09.011 · Cited by 69
Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin
Huang, C. P., Fofana, M., Chan, J., Chang, C. J., & Howell, S. B. (2014) · Metallomics · doi:10.1039/c3mt00331k · Cited by 63
Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia
Ferrao, P., Sincock, P. M., Cole, S. R., & Ashman, L. K. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00156-9 · Cited by 59
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
Gotink, K. J., Rovithi, M. N., de Haas, R. R., Honeywell, R. J., Dekker, H., Poel, D., Azijli, K., Peters, G. J., Broxterman, H. J., & Verheul, H. M. W. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0218-8 · Cited by 59
Safaei, R., Adams, P. L., Maktabi, M. H., Mathews, R. A., & Howell, S. B. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.02.016 · Cited by 56
Smith, P., Sykes, H., Fox, M. E., & Furlong, I. J. (1992) · PubMed · Cited by 56
Zong, D., Hååg, P., Yakymovych, I., Lewensohn, R., & Viktorsson, K. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.62 · Cited by 55
Lysosomal and cytosolic pH as regulators of exocytosis in mouse macrophages
Sundler, R. (1997) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1997.00262.x · Cited by 48
Zong, D., Zielinska-Chomej, K., Juntti, T., Mörk, B., Lewensohn, R., Hååg, P., & Viktorsson, K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.56 · Cited by 45
Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications
Logan, R., Funk, R. S., Axcell, E., & Krise, J. P. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.691165 · Cited by 34
Hraběta, J., Groh, T., Khalil, M. A., Poljaková, J., Adam, V., Kizek, R., Uhlı́k, J., Doktorová, H., Černá, T., Frei, E., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3066 · Cited by 24
(2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.807 · Cited by 11
Cited by
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
Self-citationModulating ROS to overcome multidrug resistance in cancer
Cui, Q., Wang, J.-Q., Assaraf, Y. G., Ren, L., Gupta, P., Wei, L., Ashby, C. R., Yang, D.-H., & Chen, Z.-S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.11.001 · Cited by 661
Self-citationHow the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S., Farhat, D., Steyaert, J.-M., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 643
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Self-citation
Metadata
- Authors
- Zhitomirsky, B., & Assaraf, Y. G.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 24
- Pages
- 23-33
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2187002261
- Cited by
- 482
- References
- 86
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.